Cerexa, Inc., a biopharmaceutical company, has awarded a $104,370 grant to researcher Michael J. Rybak, PharmD.

A professor in the Department of Pharmacy Practice, Dr. Rybak received the grant for the study: "Evaluation of Ceftraroline (CPT) Activity versus Vancomycin (VAN) Against Methicillin-resistant Staphylococcus Aureus (MRSA) Strains in an In-Vitro Simulated Endocardial Vegetation (SEV) Model."

Cerexa, headquartered in Alameda, CA, is focused on discovering, developing and commercializing a growing portfolio of novel anti-infective therapies for the treatment of serious and life-threatening infections.

The Eugene Applebaum College of Pharmacy and Health Sciences, one of the founding colleges of Wayne State University, is committed to advancing the health and well-being of society through the preparation of highly skilled health care practitioners, and through research to improve health care practices and treatment from urban to global levels.

Wayne State University is a premier urban research institution offering more than 400 academic programs through 13 schools and colleges to nearly 32,000 students.